At the "CEO: Grow with China" roundtable in Beijing on Sept 12, President of Astellas China Zhao Ping stated that as the world's second-largest pharmaceutical market with high efficiency to drive innovation, China presents huge opportunities for pharmaceutical and life science companies. "When we talk to our global team or talk with our other friends outside of China, we said we have 'fast', 'very fast' and 'China fast'. This speed, actually, it is a competitive advantage for China," Zhao said, adding that "We are investing in China, and we will continue to invest in China." #GrowWithChina